[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "ProVent"
            }
        ],
        "amendment_date": null,
        "keywords": [
            "ISUP Grade Group 1 or 2",
            "Number biopsies 1 or >1 (\u226412 months of Screening)"
        ],
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "Dendreon Corporation",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Age is \u2265 18 years"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "2. Written informed consent provided prior to the initiation of study procedures"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "3. Histologically proven adenocarcinoma of the prostate initially diagnosed \u226412 months of Screening. All biopsy slides with subject information redacted must be submitted for BICR."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "4. Prostate cancer diagnosis determined by BICR as one of the following: 4a. ISUP Grade Group 1 with 3 or more cores positive from a systematic (\u226510 cores) biopsy 4b. ISUP Grade Group 1 with \u2265 1 core positive with \u226550% cancer involvement from a systematic (\u226510 cores) biopsy 4c. ISUP Grade Group 1 from 3 or more positive cores from any combination of cores from a systematic (\u226510 cores) biopsy and MRI targeted biopsy (note: multiple cores from each MRI targeted lesion will count as 1 core) 4d. ISUP Grade Group 1 from a negative systematic (\u226510 cores) biopsy and an MRI targeted core positive with \u226550% cancer involvement 4e. ISUP Grade Group 2 from a systematic (\u226510 cores) biopsy with <50% of the total number of any cores positive for cancer 4f. ISUP Grade Group 2 from a negative systematic (\u226510 cores) biopsy and MRI targeted core(s) positive for Gleason 3+4 (see note below) 4g. ISUP Grade Group 2 from any combination of cores from a systematic (\u226510 cores) biopsy and MRI targeted biopsy (see note below) Note for 4f and 4g: the total number of positive cores must be <50% of total cores from both the systematic biopsy and MRI targeted lesions; each MRI targeted lesion, irrespective of multiple positive cores, will each count as 1 core for the total number of positive cores, e.g., 4 targeted lesions with 2 positive cores each will only add 4 to the total core count."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "5. Subject consents to standard of care for biopsy frequency of 2 on-study prostate biopsies and to provide biopsy tissue for study endpoint analysis."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "6. Estimated life expectancy \u2265 10 years"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "7. Candidate for primary curative therapy (e.g., surgery or radiation) if prostate cancer progression occurs"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "8. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "9. Adequate baseline hematologic, renal, and liver function tests as evidenced by laboratory test results within the following ranges \u226430 days prior to randomization White blood cell (WBC) count \u2265 3.0 x 10^6 cells/mL Absolute neutrophil count (ANC) \u2265 1.5 x 10^6 cells/mL Platelet count \u2265 1.0 x10^5 cells/uL Hemoglobin (Hgb) \u2265 10.0 g/dL Creatinine \u2264 1.5 mg/dL Total bilirubin \u2264 1.5 x upper limit of normal (ULN) Alanine aminotransferase (ALT) \u2264 2.0 x ULN Aspartate aminotransferase (AST) \u2264 2.0 x ULN"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 9,
                    "description": "Former therapy for prostate cancer (local or systemic)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 10,
                    "description": "2. Any previous prostatic surgical procedure that significantly changes the anatomy of prostate (at the discretion of sponsor's Medical Monitor)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 11,
                    "description": "3. Any investigational product received for prostate cancer"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 12,
                    "description": "4. Prostate biopsy specimen reveals neuroendocrine or small cell features"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "5. Primary Gleason score is \u2265 4 or any Gleason pattern 5"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "6. Any evidence of locally advanced, regional or metastatic disease, including regional and distant lymph node enlargement (Nodes \u22651.5 cm in the short axis are considered pathologic and measurable)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "7. A history of a cerebrovascular event (CVE) or transient ischemic attack (TIA)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "8. Subject has used a 5-alpha-reductase inhibitor (e.g., finasteride or dutasteride) continuously for \u2265 6 months and within 6 months prior to study Screening"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "9. Subject has a history of any other stage I-IV malignancy, except for basal or squamous cell skin cancer. The subject must be disease free and off any malignancy-related treatment for at least 5 years."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "10. Subject has prior use within 30 days of study Screening of any herbal, dietary, or alternative anti-cancer treatment or product, such as PC-SPES (or PC-x product), saw palmetto, ketoconazole, an estrogen-containing nutraceutical, or high dose calcitriol (>0.5 \u03bcg/day). The Investigator will consider herbal therapies on a case-by-case basis to determine whether they fall into the category of prohibited medications based on their potential for hormonal or anti-cancer or anti-cancer properties."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "11. Need for systemic chronic immunosuppressive therapy (e.g., anti-tumor necrosis factor alpha monoclonal antibodies, glucocorticoids)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "12. Uncontrolled, concurrent illness including, but not limited to the following: ongoing or active infection (bacterial, viral, or fungal), symptomatic congestive heart failure (New York Classification III-IV) or unstable angina pectoris within the last 6 months, or psychiatric illness that would limit compliance with study requirements as well as any condition that would preclude a subject from undergoing leukapheresis (e.g., within the previous 6 months: myocardial infarction, interventional cardiology procedure such as angioplasty or stent placement, pulmonary embolism or deep vein thrombosis)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "13. Hypogonadal (T <175 ng/dL) or on continuous testosterone replacement therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "14. Positive serology for HIV-1, HIV-2 or HTLV-1, HTLV-2"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "15. Active hepatitis B or C"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "16. Any medical intervention, any other condition, or any other circumstance which, in the opinion of the investigator or the sponsor's Medical Monitor, could compromise adherence with study requirements or otherwise compromise the study's objectives."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "MALE",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "The ProVent Study is designed to look at subjects who recieve sipuleucel-T compared to\r\n      control subjects followed on AS. The study will enroll subjects being followed by AS and\r\n      initially diagnosed within 12 months prior to Screening with either ISUP Grade Group 1 or 2\r\n      adenocarcinoma of the prostate.\r\n\r\n      The Screening Phase will begin at the completion of the informed consent process and\r\n      continues until randomization. After Screening assessments are completed, eligible subjects\r\n      will be randomized 2:1 to the sipuleucel-T arm or the control arm. Subjects randomized to\r\n      sipuleucel-T arm will receive product as described in the sipuleucel-T approved label.\r\n\r\n      Subjects will undergotheir first leukapheresis within 60 days of randomization.\r\n\r\n      Subjects randomized to the control arm will be followed on AS. The Active Phase will begin at\r\n      randomization and continues through completion of the end of Active Phase study visit (within\r\n      30 days of Biopsy 2). Once a subject from either the sipuleucel-T or control arms completes\r\n      the end of Active Phase visit, they will enter the Follow-up Phase and complete Follow-up\r\n      Phase visits every 6 months starting from their last Active Phase visit. The Follow-up Phase\r\n      visits end when the last subject enrolled completes Biopsy 2 and end of Active Phase visit or\r\n      until the study is terminated by the sponsor.",
        "official_title": "A Randomized Phase 3, Open-Label Trial of Sipuleucel-T Administered To Patients On Active Surveillance For Newly Diagnosed Prostate Cancer",
        "_phase_sort_order": 0,
        "collaborators": [
            {
                "name": "PRA Health Sciences",
                "functional_role": "LABORATORY"
            }
        ],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Once all subjects have completed at least 3 years following randomization",
                "name": "To assess the efficacy of sipuleucel-T in reducing histopathologic reclassification to a higher Gleason grade in prostate cancer subjects on active surveillance (AS)",
                "description": "Proportion of subjects without histological reclassification (Gleason group upgrade) within 36 months of randomization as determined by Blinded Independent Central Review (BICR)\r\no Upgrade is defined as subjects at randomization with either International Society of Urological Pathology (ISUP) Grade Group 1 (Gleason 3+3) upgraded to Grade Group 2 (Gleason 3+4) or higher or subjects at randomization with Grade Group 2 upgraded to Grade Group 3 (Gleason 4+3) or higher.",
                "type_code": "PRIMARY"
            }
        ],
        "phase": "III",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 2,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03686683",
        "biomarkers": [],
        "classification_code": null,
        "current_trial_status_date": "2019-10-08",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma of the Prostate",
                    "PRAD",
                    "Adenocarcinoma of Prostate"
                ],
                "nci_thesaurus_concept_id": "C2919",
                "name": "Prostate Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C48596",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Invasive Prostate Carcinoma",
                    "Infiltrating Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C48596",
                "name": "Invasive Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9480",
                    "C4863"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Reproductive System Tumor",
                    "Neoplasm of Reproductive System",
                    "Reproductive Tumor",
                    "Tumor of the Reproductive System",
                    "Tumor of Reproductive System",
                    "Neoplasm of the Reproductive System",
                    "Reproductive Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3674",
                "name": "Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156482",
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma of Prostate",
                    "Prostate cancer, NOS",
                    "Cancer of Prostate",
                    "Prostate Carcinoma",
                    "Carcinoma of the Prostate",
                    "Cancer of the Prostate"
                ],
                "nci_thesaurus_concept_id": "C4863",
                "name": "Prostate Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181196",
                    "C7378"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C9480",
                "name": "Invasive Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C8505"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Neoplasm of Prostate",
                    "Malignant Tumor of the Prostate",
                    "Malignant Neoplasm of the Prostate",
                    "Malignant Prostate Tumor",
                    "Malignant Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C7378",
                "name": "Malignant Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C3343"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of the Prostate",
                    "Neoplasm of Prostate",
                    "Prostate Tumor",
                    "Tumor of the Prostate",
                    "Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C3343",
                "name": "Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C26865"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Male Reproductive System",
                    "Malignant Male Reproductive System Tumor",
                    "Male reprod. system cancer, NOS",
                    "Malignant Neoplasm of the Male Reproductive System",
                    "Malignant Tumor of Male Reproductive System",
                    "Malignant Neoplasm of Male Reproductive System",
                    "Male reproductive system cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C8561",
                "name": "Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C36076"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36076",
                "name": "Malignant Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Disease"
                ],
                "nci_thesaurus_concept_id": "C26865",
                "name": "Prostate Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genitourinary Disorder",
                    "Urogenital Disease"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181196",
                "name": "Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C164141"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disorder of Male Reproductive System",
                    "Male Reproductive System Disease"
                ],
                "nci_thesaurus_concept_id": "C27019",
                "name": "Male Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "infiltrating cancer",
                    "invasive cancer",
                    "Infiltrating Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8505",
                "name": "Invasive Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Genitourinary Neoplasm",
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genital Disorders",
                    "Reproductive System Disease",
                    "Disorder of Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C4875",
                "name": "Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of Male Reproductive System",
                    "Tumor of the Male Reproductive System",
                    "Neoplasm of Male Reproductive System",
                    "Neoplasm of the Male Reproductive System",
                    "Male Reproductive System Tumor"
                ],
                "nci_thesaurus_concept_id": "C3054",
                "name": "Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3674",
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "P17-1",
        "active_sites_count": 3,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Vaccine"
                        ],
                        "nci_thesaurus_concept_id": "C923",
                        "name": "Vaccine Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Dendritic Cell-based Cancer Vaccine"
                        ],
                        "nci_thesaurus_concept_id": "C28310",
                        "name": "Dendritic Cell Vaccine",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C28308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Watchful Waiting",
                            "Observation",
                            "Active Surveillance"
                        ],
                        "nci_thesaurus_concept_id": "C15722",
                        "name": "Patient Observation",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16205"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antiproliferative Drugs",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Drug",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Neoplasm Vaccine",
                            "Cancer Vaccine",
                            "Tumor Vaccine"
                        ],
                        "nci_thesaurus_concept_id": "C1663",
                        "name": "Antineoplastic Vaccine",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C923"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Health Care Activity",
                            "Healthcare"
                        ],
                        "nci_thesaurus_concept_id": "C16205",
                        "name": "Healthcare Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Adoptive Cell Transfer Agent",
                            "Adoptive Cell Therapy Agent",
                            "ACT Agent",
                            "Adoptive Cellular Therapy Agent",
                            "Adoptive Cell-based Agent"
                        ],
                        "nci_thesaurus_concept_id": "C142078",
                        "name": "Adoptive Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biopharmaceuticals",
                            "Biologicals",
                            "Biologics",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Immunotherapeutic",
                            "Antineoplastic Biological Response Modifier",
                            "Antineoplastic BRM",
                            "Anti-cancer Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biological",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Provenge"
                        ],
                        "nci_thesaurus_concept_id": "C1985",
                        "name": "Sipuleucel-T",
                        "description": "A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells.  Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129826",
                            "C1987"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunopotentiators",
                            "Biological Response Modifier",
                            "BRM",
                            "Immune Regulators",
                            "Immune Modulators",
                            "Immune Mediators",
                            "Biomodulators",
                            "Immunomodulating Agent",
                            "Immunomodulators",
                            "Immunotherapeutic Agent",
                            "Immunomodulatory Agent",
                            "Immunotherapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "dendritic cells pulsed with tumor peptide",
                            "DC tumor peptide vaccine"
                        ],
                        "nci_thesaurus_concept_id": "C1987",
                        "name": "Dendritic Cell Tumor Peptide Vaccine",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C28310"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C28308",
                        "name": "APC Vaccine",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1663"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Immune Cells",
                            "Anti-cancer Immune Cell"
                        ],
                        "nci_thesaurus_concept_id": "C129826",
                        "name": "Antineoplastic Immune Cell",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821",
                            "C142078",
                            "C129820"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Control Arm: Active Surveillance",
                "description": "Subjects randomized to the control arm will be followed on Active Surveillance described in the schedule of events.",
                "type": "NO_INTERVENTION"
            },
            {
                "interventions": [],
                "name": "Treatment Group: Sipuleucel-T",
                "description": "Sipuleucel-T is an autologous cellular immunotherapy available as a suspension for intravenous infusion. Subjects randomized to sipuleucel-T arm will receive 3 infusions of sipuleucel-T at approximately 2-week intervals.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2018-03353",
        "why_study_stopped": null,
        "brief_summary": "The ProVent study is a randomized, open-label study designed to assess the efficacy of\r\n      sipuleucel-T in reducing the progression of lower risk non-metastatic prostate cancer\r\n      compared to subjects followed on active surveillance as standard of care.",
        "brief_title": "Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer",
        "status_history": [
            {
                "status_date": "2019-10-08T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2018-10-18T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 450,
        "_current_trial_status_sort_order": 7,
        "start_date": "2018-10-18",
        "record_verification_date": "2022-01-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Randomized Controlled Trial"
        },
        "acronym": "ProVent",
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Prostate"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2023-05-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]